COMPANY
Virion Therapeutics
FDA-cleared device company Clinical Phase 1
Timeline
- Trial start Phase 1: Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06070051 | Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy | Phase 1 | Completed | Sep 26, 2023 | Mar 31, 2026 (actual) |